BNP PARIBAS FINANCIAL MARKETS - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2020$4,441,492,000
+0.9%
4,327,000
+8.5%
0.01%
-25.0%
Q2 2020$4,402,631,000
+45.8%
3,988,000
+32.5%
0.01%
+33.3%
Q1 2020$3,019,381,000
-39.1%
3,009,000
-30.1%
0.01%
-33.3%
Q4 2019$4,957,357,000
-40.7%
4,303,000
-41.2%
0.01%
-40.0%
Q3 2019$8,357,916,000
+3.2%
7,317,000
+6.9%
0.02%
-6.2%
Q2 2019$8,097,741,000
+156.5%
6,847,000
+192.1%
0.02%
+128.6%
Q1 2019$3,157,602,0002,344,0000.01%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2019
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders